/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

B

Bojana Milojkovic Kerklaan

Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital(NL)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

17

Papers

596

Citations

11

h-index

11

i10-index

Bojana Milojkovic Kerklaan is an academic researcher from Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Brain Metastases and Treatment & Glioma Diagnosis and Treatment. The author has an h-index of 11, co-authored 15 publications.

Research Topics

Lung Cancer Treatments and Mutations Brain Metastases and Treatment Glioma Diagnosis and Treatment HER2/EGFR in Cancer Research Nanoplatforms for cancer theranostics

Papers by this author

works

A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies

2016 · Investigational New Drugs · 60 citations

https://doi.org/10.1007/s10637-015-0320-9

Geert A. Cirkel Bojana Milojkovic Kerklaan Frédéric Vanhoutte Annegret Van der Aa

Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023

2012 · Cancer Chemotherapy and Pharmacology · 21 citations

https://doi.org/10.1007/s00280-012-1972-1

Bojana Milojkovic Kerklaan Véronique Dièras Christophe Le Tourneau Marja Mergui‐Roelvink

Research topics

topics

Lung Cancer Treatments and Mutations

Brain Metastases and Treatment

Glioma Diagnosis and Treatment

HER2/EGFR in Cancer Research

Nanoplatforms for cancer theranostics

Chat about Author

Papers

Chat

Click to start Chat